LH
Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$257.14
-0.94% today
Updated 2026-04-29
Market cap
$21.19B
P/E ratio
24.56
P/S ratio
1.52x
EPS (TTM)
$10.47
Dividend yield
1.11%
52W range
$237 – $292
Volume
0.6M
Laboratory Corporation of America Holdings (LH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
6.28%
Operating margin
10.50%
ROE
10.50%
ROA
5.12%
Debt/equity
0.84x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $3.59B | $431.60M | 42.59% | 19.41% | 12.02% |
| 2007 | $4.07B | $476.80M | 41.57% | 19.10% | 11.72% |
| 2008 | $4.51B | $464.50M | 41.59% | 18.71% | 10.31% |
| 2009 | $4.69B | $543.30M | 41.98% | 19.94% | 11.57% |
| 2010 | $5.00B | $558.20M | 41.92% | 19.56% | 11.16% |
| 2011 | $5.54B | $519.70M | 41.04% | 17.11% | 9.38% |
| 2012 | $5.67B | $583.10M | 39.67% | 18.05% | 10.28% |
| 2013 | $5.81B | $573.80M | 38.28% | 17.06% | 9.88% |
| 2014 | $6.01B | $511.20M | 36.65% | 15.14% | 8.50% |
| 2015 | $8.68B | $436.90M | 33.45% | 11.55% | 5.03% |
| 2016 | $9.64B | $732.10M | 32.99% | 13.61% | 7.59% |
| 2017 | $10.44B | $1.27B | 33.18% | 13.07% | 12.15% |
| 2018 | $11.33B | $883.70M | 28.03% | 11.70% | 7.80% |
| 2019 | $11.55B | $823.80M | 28.15% | 11.51% | 7.13% |
| 2020 | $13.98B | $1.56B | 35.43% | 17.49% | 11.13% |
| 2021 | $13.14B | $2.38B | 38.01% | 23.21% | 18.10% |
| 2022 | $11.86B | $1.28B | 31.26% | 12.11% | 10.78% |
| 2023 | $12.16B | $418.00M | 27.67% | 5.97% | 3.44% |
| 2024 | $13.01B | $746.00M | 27.86% | 8.35% | 5.73% |
| 2025 | $13.95B | $876.50M | 26.75% | 10.87% | 6.28% |